Advanced search
Publication Cover
Autoimmunity Volume 38, 2005 - Issue 2
Submit an article Journal homepage
264
Views
61
CrossRef citations to date
0
Altmetric
Original Article

IVIg therapy in autoimmunity and related disorders: our experience with a large cohort of patients

Yehuda Shoenfeld Center for Autoimmune Diseases, Department of Internal Medicine “B”, Sheba Medical Center, Tel-Hashomer, Ramat Gan, 52621, Israel; Sackler Faculty of Medicine, Tel-Aviv University, Tel Aviv, Israel; Incumbent of the Laura Schwarz-Kipp, Chair for Research of Autoimmune Diseases, Tel-Aviv University, Tel Aviv, IsraelCorrespondence[email protected]
&
Uriel Katz Center for Autoimmune Diseases, Department of Internal Medicine “B”, Sheba Medical Center, Tel-Hashomer, Ramat Gan, 52621, Israel
Pages 123-137 | Received 12 Dec 2004, Accepted 25 Jan 2005, Published online: 07 Jul 2009

Refernces

  • Knezevic-Maramica I, Kruskall MS. Intravenous immune globulins: An update for clinicians. Transfusion 2003; 43:1460–1480.
  • Raouva L, Rovensky J, Shoenfeld Y. High dose intravenous immunoglobulins: A new step in the treatment of systemic lupus erythematosus. IMAJ 2000;:388–392.
  • Bar-Dayan Y, Karevi SV, Pashov A, Shoenfeld Y, Kazatchkine MD. Anti-inflammatory effects of intravenous immuno-globulin (Wig). In: Eibl M, Huber H, editors. Symposium in immunology. Berlin: Springer-Verlag; 2002. p 171–184.
  • Blasczyk R, Westhoff U, Grosse-Wilde H. Soluble CD4, CD8, and HLA molecules in commercial immunoglobulin preparations. Lancet 1993;341: 789–790.
  • Kekow J, Reinhold D, Pap T, Ansorge S. Intravenous immunoglobulins and transforming growth factor beta. Lancet 1998;351:184–185.
  • Krause I, Wu R, Sherer Y, Patanik M, Peter JB, Shoenfeld Y. In vitro antiviral and antibacterial activity of commercial intravenous immunoglobulin preparations-a potential role for adjuvant intravenous immunoglobulin therapy in infec-tious diseases. Transfus Med 2002;12:133–139.
  • Abu-Shakra M, Buskila D, Shoenfeld Y. Introduction-idiotypes and anti-idiotypes. In: Shoenfeld Y, Kennedy RC, Ferrone S, editors. Idiotypes in medicine: Autoimmunity, infection and cancer. Amsterdam: Elsevier Science B.V. 1997. p 53–74.
  • Sherer Y, Levy Y, Shoenfeld Y. Intravenous immunoglobulin (IVIg) in autoimmune diseases-expanding indications and increasing specificity. 85–91, Chapter 13. In: Heidt PJ, Rusch VD, van Der Waaij D, editors. Old Herborn University Seminar Monograph. Horborn Litterae. 2001.
  • Shoenfeld Y. 5th International Symposium on IVIG: IVIG in the third millennium. In: 2003 25–27 September; Interlaken; 2003.
  • Imbach P, Barandun S, d'Apuzzo V, Baumgartner C, Hirt A, More11 A, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981;1:1228–1231.
  • Rauova L, Lukac J, Levy Y, Rovensky J, Shoenfeld Y. High-dose intravenous immunoglobulins for lupus nephritis-a salvage immunomodulation. Lupus 2001;10:209–213.
  • Sherer Y, Levy Y, Shoenfeld Y. Intravenous immunoglobulin (IVIG) therapy in autoimmune diseases - SLE, anti-phospholipid syndrome, vasculitis. What is new? In: RHEUMA 21st (http://www.rheuma21st.com/index.html) 1999.
  • Sherer Y, Shoenfeld Y. Summary of an Expert Conference on the Use of WIG. Expert Conference on the Use of IVIG; 2003 14–15 February; Berne. 2003.
  • Sultan Y, Kazatchkine MD, Maisonneuve P, Nydegger UE. Anti-idiotypic suppression of autoantibodies to factor VIII (antihaemophilic factor) by high-dose intravenous gamma-globulin. Lancet 1984;2:765–768.
  • Rossi F, Dietrich G, Kazatchkine MD. Antiidiotypic suppression of autoantibodies with normal polyspecific immunoglobulins. Res Immunol 1989;140:19–31.
  • Lacroix-Desmazes S, Mouthon L, Spalter SH, Kaveri S, Kazatchkine MD. Immunoglobulins and the regulation of autoimmunity through the immune network. Chin Exp Rheumatol 1996;14\(Suppl. 15):S9–S15.
  • Mouthon L, Kaveri S, Kazatchkine M. Immune modulating effects of intravenous immunoglobulin (IVIg) in autoimmune diseases. Transfus Sci 1994;15:393–408.
  • Nydegger UE, Sultan Y, Kazatchkine MD. The concept of anti-idiotypic regulation of selected autoimmune diseases by intravenous immunoglobulin. Chin Immunol Immunopathol 1989;53:572–582.
  • Rossi F, Dietrich G, Kazatchkine MD. Anti-idiotypes against autoantibodies in normal immunoglobulins: Evidence for network regulation of human autoimmune responses. Immunol Rev 1989;110:135–149.
  • Krause I, Blank M, Kopolovic J, Afek A, Goldberg I, Tomer Y, et al. Abrogation of experimental systemic lupus erythematosus and primary antiphospholipid syndrome with intravenous gamma globulin. J Rheumatol 1995;22:1068–1074.
  • Shoenfeld Y, Rauova L, Gilburd B, Kvapil F, Goldberg I, Kopolovic J, et al. Efficacy of IVIG affinity-purified anti-double-stranded DNA anti-idiotypic antibodies in the treatment of an experimental murine model of systemic lupus erythematosus. Int Immunol 2002;14:1303–1311.
  • Wu R, Shoenfeld Y, Sherer Y, Patnaik M, Matsuura E, Gilburd B, et al. Anti-idiotypes to oxidized LDL antibodies in intravenous immunoglobulin preparations-possible immu-

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.